Journal Article

Lectin-Like Transcript 1 (LLT1) Checkpoint: A Novel Independent Prognostic Factor in HPV-Negative Oropharyngeal Squamous Cell Carcinoma

Gonzalez, Segundo, Sordo-Bahamonde, Christian, Allonca, Eva, Pozo-Agundo, Esperanza, Hermida-Prado, Francisco, García-Pedrero, Juana M., Montoro-Jiménez, Irene, Vallina-Álvarez, Aitana, Sanchez-Canteli, Mario, Rodrigo, Juan P., Álvarez-Marcos, César

2020

Overview

Lectin-like transcript 1 (LLT1) expression by tumor cells contributes to immune evasion, thereby emerging as a natural killer (NK) cell-mediated immunotherapeutic target. This study is the first to investigate LLT1 expression (encoded by CLEC2D gene) in head and neck cancers to ascertain its impact on patient prognosis. LLT1 expression was analyzed by immunohistochemistry in a homogeneous cohort of human papillomavirus (HPV)-negative oropharyngeal squamous cell carcinomas (OPSCC), and correlated with clinical data. Results were further validated using transcriptomic data from the TCGA database. Tumoral LLT1 expression was detected in 190/221 (86%) OPSCC specimens, whereas normal pharyngeal epithelium was negative. Patients harboring LLT1-positive tumors showed significantly lower disease-specific (DSS) and overall survival (OS) (p = 0.049 and p = 0.036, respectively, log-rank test). High density of LLT1-positive tumor-infiltrating lymphocytes (TIL) was also frequently detected in 160 (73%) OPSCC samples, and significantly associated with better DSS and OS (p < 0.001 and p = 0.007, respectively). Multivariate Cox analysis further revealed that tumoral LLT1 expression and infiltration of LLT1-positive TIL were independent prognostic factors for DSS and OS. CLEC2D mRNA levels are also significantly increased in primary tumors compared to normal tissue. Strikingly, the prognostic impact of CLEC2D mRNA levels varied depending on HPV status in OPSCC, and among distinct cancer types. CLEC2D expression was significantly correlated with NK cell infiltration using the MCP-counter model. These findings uncover LLT1/CLEC2D as an independent prognostic factor in HPV-negative OPSCC, and a potential novel target for immunotherapy.

• Publisher: MDPI AG,MDPI
• Subject: Cancer / Classification / CLEC2D / Epithelium / Genes / Glycoproteins / Head & neck cancer / head and neck squamous cell carcinomas / Human papillomavirus / immune checkpoint / Immune system / Immunohistochemistry / Immunotherapy / Infiltration / lectin-like transcript 1 / Lectins / LLT1 / Lymphocytes / Medical prognosis / Metastases / Natural killer cells / NK cell / Oropharyngolaryngeal carcinoma / Patients / Pharynx / Proteins / Squamous cell carcinoma / Transcription / Tumor cells / Tumor-infiltrating lymphocytes / Tumors